September 2007

• Gene therapy might not have caused patient's death

  Standfirst

  Case was complicated by immunosuppressant drug regime.

  news@nature.com

  (19 September 2007); doi:10.1038/449270b

• Biotechs go generic: The same but different

  Standfirst

  As several lucrative protein-based drugs are poised to go off patent, makers of biopharmaceuticals argue that their products are too complex to be reproduced as generics. Heidi Ledford investigates how close 'biosimilar' drugs can get to the original.

  news@nature.com

  (19 September 2007); doi:10.1038/449274a

• Gene knockout extends life of mice with ALS

  Standfirst

  Deleting a single gene almost doubles lifespan.

  news@nature.com

  (13 September 2007); doi:10.1038/news070910-10

• Long-held theory is in danger of losing its nerve

  Standfirst

  Doubts raised over influential work on neurotransmitter release.

  news@nature.com

  (12 September 2007); doi:10.1038/449124b

• Schizophrenia genes 'favoured by evolution'

  Standfirst

  Sequences linked to brain disorder show hallmarks of natural selection.

  news@nature.com

  (5 September 2007); doi:10.1038/news070903-6

• High hopes for new schizophrenia drugs

  Standfirst

  Drug trial hailed as first major breakthrough for 50 years.

  news@nature.com

  (2 September 2007); doi:10.1038/news070827-9

• Smoking stays in your genes after you quit

  Standfirst

  Cigarette habit may leave a molecular mark.

  news@nature.com

  (30 August 2007); doi:10.1038/news070827-5

• Mighty mice could yield human treatments

  Standfirst

  Super-sized animals may pave way for new drugs and bigger livestock.

  news@nature.com

  (29 August 2007); doi:10.1038/news070827-3